Abstract:Gene expression involves transcription and translation. Despite large datasets and increasingly powerful methods devoted to calculating genetic variants’ effects on transcription, discrepancy between messenger RNA and protein levels hinders the systematic interpretation of the regulatory effects of disease-associated variants. Accurate models of the sequence determinants of translation are needed to close this gap and to interpret disease-associated variants that act on translation. Here we present Translatomer, a multimodal transformer framework that predicts cell-type-specific translation from messenger RNA expression and gene sequence. We train the Translatomer on 33 tissues and cell lines, and show that the inclusion of sequence improves the prediction of ribosome profiling signal, indicating that the Translatomer captures sequence-dependent translational regulatory information. The Translatomer achieves accuracies of 0.72 to 0.80 for the de novo prediction of cell-type-specific ribosome profiling. We develop an in silico mutagenesis tool to estimate mutational effects on translation and demonstrate that variants associated with translation regulation are evolutionarily constrained, both in the human population and across species. In particular, we identify cell-type-specific translational regulatory mechanisms independent of the expression quantitative trait loci for 3,041 non-coding and synonymous variants associated with complex diseases, including Alzheimer’s disease, schizophrenia and congenital heart disease. The Translatomer accurately models the genetic underpinnings of translation, bridging the gap between messenger RNA and protein levels as well as providing valuable mechanistic insights for uninterpreted disease variants. A transformer-based approach called Translatomer is presented, which models cell-type-specific translation from messenger RNA expression and gene sequence, bridging the gap between messenger RNA and protein levels as well as providing a mechanistic insight into the genetic regulation of translation.

Prioritization of genes for translation: a computational approach

A Meta-Analysis Strategy for Gene Prioritization Using Gene Expression, SNP Genotype, and eQTL Data

NRSSPrioritize: Associating Protein Complex and Disease Similarity Information to Prioritize Disease Candidate Genes

Evaluation of phenotype-driven gene prioritization methods for Mendelian diseases

ProDiGe: PRioritization Of Disease Genes with multitask machine learning from positive and unlabeled examples

Prioritization and functional validation of target genes from single-cell transcriptomics studies

Prioritising genetic findings for drug target identification and validation

Deep Learning Prediction of Ribosome Profiling with Translatomer Reveals Translational Regulation and Interprets Disease Variants

Sequence-Based Prioritization of Nonsynonymous Single-Nucleotide Polymorphisms for the Study of Disease Mutations

Refined preferences of prioritizers improve intelligent diagnosis for Mendelian diseases

Efficient Manipulations of Synonymous Mutations for Controlling Translation Rate: An Analytical Approach

Integrating gene expression and protein-protein interaction network to prioritize cancer-associated genes

Uncover Disease Genes by Maximizing Information Flow in the Phenome-Interactome Network.

Walking on Multiple Disease-Gene Networks to Prioritize Candidate Genes.

A graph theoretical approach to experimental prioritization in genome-scale investigations

Biological Random Walks: integrating heterogeneous data in disease gene prioritization

Data-driven prioritization of genetic disorders for global genomic newborn screening programs

Comparison of in silico strategies to prioritize rare genomic variants impacting RNA splicing for the diagnosis of genomic disorders

Constructing Human Phenome-Interactome Networks for the Prioritization of Candidate Genes

Critical assessment of variant prioritization methods for rare disease diagnosis within the rare genomes project

Prioritization of orphan disease-causing genes using topological feature and GO similarity between proteins in interaction networks